top of page
Recent Publications
NEW
​AACR Annual Meeting 2025
Differential T cell response to anti-PD1 in breast cancer sub-types is driven by activity of intra-tumoral immune cells
AACR Special Conference in Cancer Research
Identification of tumor microenvironment informed exosome biomarkers for predicting response to anti-PD1 therapy
.jpg)
39th Annual Meeting SITC
PLN-101095 a selective inhibitor of integrins αvβ8 and αvβ1 augments the therapeutic benefits of immune checkpoint
blockade therapy in human tumor histoculture model
39th Annual Meeting SITC
Identifying and targeting resistance factors upon immune checkpoint inhibition for better combinatorial treatment
strategies leading to improved outcomes
Immunocon 2024
Effect of treatment with immune checkpoint inhibitors on different immune sub-populations in the tumor microenvironment
AACR Annual Meeting 2024
Role of CD4/CD8 double positive T cells in modulating response to anti-PD-1 treatment in renal cell carcinoma
Nature Communications
Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer
38th Annual Meeting SITC
Pre-Selection of patients who would respond to combination of chemotherapy and low dose immunotherapy using human histoculture platform and low dose immunotherapy using human histoculture platform
38th Annual Meeting SITC
Identification of effective treatment regimens for ovarian cancer using tumor histoculture platform
Additional Publications
AACR TME 2023
Characterization of macrophage population in Head and Neck Squamous Cell Carcinoma and Renal Cell Carcinoma and their role in modulating immune checkpoint blockade response
AACR Annual Meeting 2023
Simultaneous comparison of response to two different anti-PD1 drugs in the same patient using a human tumor histo-culture platform
AACR Annual Meeting 2023
Can TKI failed patients be rescued with anti-PD1 Therapy?
37th Annual SITC 2022
SITC TME 2022
AACR 2022
SITC 2021
bottom of page